Chitosan chelated Fe3+ nanocomposite for enhanced biomedical and environmental applications

Chitosan, a biopolymer known for its biocompatibility, biodegradability, and chemical adaptability, has attracted significant attention in scientific research. Chitosan-metal nanocomposites represent an emerging area of exploration. Among these, Chitosan-Fe nanocomposite has gained prominence due to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanocomposites 2023-12, Vol.9 (1), p.159-170
Hauptverfasser: Gumathannavar, Rutuja, Thormothe, Anil, Bhutada, Pankhudi, Shirolkar, Mandar M, Kulkarni, Atul, Koratkar, Santosh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Chitosan, a biopolymer known for its biocompatibility, biodegradability, and chemical adaptability, has attracted significant attention in scientific research. Chitosan-metal nanocomposites represent an emerging area of exploration. Among these, Chitosan-Fe nanocomposite has gained prominence due to its various applications, including photoremediation, bioimaging, and drug delivery systems. In this study, we delved into the synthesis and physicochemical properties of Chitosan-Fe nanocomposites. These nanocomposites exhibited a spherical structure with active binding sites that allowed for the functionalization of Fe3+ ions on their surface. Density functional theory simulations corroborated this alteration, demonstrating changes in surface charge properties resulting in increased mechanical strength. A key finding of this study is the enhanced antibacterial activity exhibited by the Cs-Fe nanocomposites against both Escherichia coli (62.5 µg/mL) and Staphylococcus aureus (125.25 µg/mL), surpassing that of bare Chitosan nanoparticles. Furthermore, our investigation confirms the therapeutic safety of the Chitosan-Fe nanocomposite. The cell viability calculated by MTT assay and accepted therapeutic dose concentration for CS-Fe NC was 125 ug/mL whereas for CSNP < 15.62 µg/mL. This underscores the nanocomposite’s potential in biomedical applications. In addition to its biomedical promise, the Chitosan-Fe nanocomposite also demonstrates remarkable potential in environmental remediation, particularly in the removal of hexavalent chromium.
ISSN:2055-0324
2055-0332
DOI:10.1080/20550324.2023.2281833